162 related articles for article (PubMed ID: 10336487)
1. Down-regulation of melanocortin receptor signaling mediated by the amino terminus of Agouti protein in Xenopus melanophores.
Ollmann MM; Barsh GS
J Biol Chem; 1999 May; 274(22):15837-46. PubMed ID: 10336487
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo.
Ollmann MM; Lamoreux ML; Wilson BD; Barsh GS
Genes Dev; 1998 Feb; 12(3):316-30. PubMed ID: 9450927
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Agouti-related protein binding to melanocortin receptors.
Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
[TBL] [Abstract][Full Text] [Related]
4. A synthetic human Agouti-related protein-(83-132)-NH2 fragment is a potent inhibitor of melanocortin receptor function.
Quillan JM; Sadée W; Wei ET; Jimenez C; Ji L; Chang JK
FEBS Lett; 1998 May; 428(1-2):59-62. PubMed ID: 9645475
[TBL] [Abstract][Full Text] [Related]
5. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
6. Antagonist and agonist activities of the mouse agouti protein fragment (91-131) at the melanocortin-1 receptor.
Eberle AN; Bódi J; Orosz G; Süli-Vargha H; Jäggin V; Zumsteg U
J Recept Signal Transduct Res; 2001 Feb; 21(1):25-45. PubMed ID: 11693171
[TBL] [Abstract][Full Text] [Related]
7. Melanocortin receptor binding determinants in the agouti protein.
Kiefer LL; Veal JM; Mountjoy KG; Wilkison WO
Biochemistry; 1998 Jan; 37(4):991-7. PubMed ID: 9454589
[TBL] [Abstract][Full Text] [Related]
8. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors.
Tota MR; Smith TS; Mao C; MacNeil T; Mosley RT; Van der Ploeg LH; Fong TM
Biochemistry; 1999 Jan; 38(3):897-904. PubMed ID: 9893984
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein.
Ollmann MM; Wilson BD; Yang YK; Kerns JA; Chen Y; Gantz I; Barsh GS
Science; 1997 Oct; 278(5335):135-8. PubMed ID: 9311920
[TBL] [Abstract][Full Text] [Related]
10. Molecular pharmacology of Agouti protein in vitro and in vivo.
Barsh GS; Ollmann MM; Wilson BD; Miller KA; Gunn TM
Ann N Y Acad Sci; 1999 Oct; 885():143-52. PubMed ID: 10816647
[TBL] [Abstract][Full Text] [Related]
11. Novel agouti-related-protein-based melanocortin-1 receptor antagonist.
Thirumoorthy R; Holder JR; Bauzo RM; Richards NG; Edison AS; Haskell-Luevano C
J Med Chem; 2001 Nov; 44(24):4114-24. PubMed ID: 11708914
[TBL] [Abstract][Full Text] [Related]
12. Common requirements for melanocortin-4 receptor selectivity of structurally unrelated melanocortin agonist and endogenous antagonist, Agouti protein.
Oosterom J; Garner KM; den Dekker WK ; Nijenhuis WA; Gispen WH; Burbach JP; Barsh GS; Adan RA
J Biol Chem; 2001 Jan; 276(2):931-6. PubMed ID: 11024027
[TBL] [Abstract][Full Text] [Related]
13. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
Mountjoy KG; Willard DH; Wilkison WO
Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
[TBL] [Abstract][Full Text] [Related]
14. Molecular determination of agouti-related protein binding to human melanocortin-4 receptor.
Yang Y; Chen M; Lai Y; Gantz I; Yagmurlu A; Georgeson KE; Harmon CM
Mol Pharmacol; 2003 Jul; 64(1):94-103. PubMed ID: 12815165
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship of (1-aryl-2-piperazinylethyl)piperazines: antagonists for the AGRP/melanocortin receptor binding.
Arasasingham PN; Fotsch C; Ouyang X; Norman MH; Kelly MG; Stark KL; Karbon B; Hale C; Baumgartner JW; Zambrano M; Cheetham J; Tamayo NA
J Med Chem; 2003 Jan; 46(1):9-11. PubMed ID: 12502354
[TBL] [Abstract][Full Text] [Related]
16. Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action.
Ebihara K; Ogawa Y; Katsuura G; Numata Y; Masuzaki H; Satoh N; Tamaki M; Yoshioka T; Hayase M; Matsuoka N; Aizawa-Abe M; Yoshimasa Y; Nakao K
Diabetes; 1999 Oct; 48(10):2028-33. PubMed ID: 10512369
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of ligand binding to the melanocortin receptors.
Kiefer LL; Ittoop OR; Bunce K; Truesdale AT; Willard DH; Nichols JS; Blanchard SG; Mountjoy K; Chen WJ; Wilkison WO
Biochemistry; 1997 Feb; 36(8):2084-90. PubMed ID: 9047307
[TBL] [Abstract][Full Text] [Related]
18. High-resolution NMR structure of the chemically-synthesized melanocortin receptor binding domain AGRP(87-132) of the agouti-related protein.
McNulty JC; Thompson DA; Bolin KA; Wilken J; Barsh GS; Millhauser GL
Biochemistry; 2001 Dec; 40(51):15520-7. PubMed ID: 11747427
[TBL] [Abstract][Full Text] [Related]
19. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo.
Rossi M; Kim MS; Morgan DG; Small CJ; Edwards CM; Sunter D; Abusnana S; Goldstone AP; Russell SH; Stanley SA; Smith DM; Yagaloff K; Ghatei MA; Bloom SR
Endocrinology; 1998 Oct; 139(10):4428-31. PubMed ID: 9751529
[TBL] [Abstract][Full Text] [Related]
20. Inverse agonism gains weight.
Adan RA; Kas MJ
Trends Pharmacol Sci; 2003 Jun; 24(6):315-21. PubMed ID: 12823958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
